Evidence map›Paper›PMID 10822374›Full record

ArticleOncogene2000

HTLV-1 Tax protein sensitizes cells to apoptotic cell death induced by DNA damaging agents.

S Y Kao, F J Lemoine, S J Mariott

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.Apoptosis : an international journal on programmed cell death · 2008
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. T-cell control by human T-cell leukemia/lymphoma virus type 1.International journal of hematology · 2003
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S Y KaoDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA.
F J Lemoine
S J Mariott
Baylor College of Medicine · US

Funding

Mechanisms of Cellular Transformation by HTLV-1 TAXR01CA077371 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MARRIOTT, SUSAN J · 1999 to 2008
$2.3M
NCI NIH HHS CA09197NCI NIH HHS CA-77371
6 · The paper itself

Abstract

Transient HTLV-1 Tax expression suppresses cellular nucleotide excision repair, and this effect correlates with Tax transactivation of the proliferating cell nuclear antigen promoter. The inability to repair DNA damage typically induces apoptotic cell death. Therefore, we investigated the effect of Tax-mediated suppression of DNA repair on apoptosis in stable Tax-expressing cells. Constitutive Tax expression reduced cellular nucleotide excision repair activity compared with parental and control cells. Tax-expressing cells were also more sensitive to apoptosis induced by DNA damaging agents than control cells. Even though Tax-expressing cells displayed reduced DNA repair, they showed increased DNA replication following UV damage. These results suggest that Tax suppresses the cell's ability to repair DNA damage and stimulates DNA replication even in the presence of damage. The inability to repair DNA damage is likely to stimulate apoptotic cell death in the majority of Tax-expressing cells while the ability to promote DNA replication may also allow the survival of a small population of cells. We propose that together these effects contribute to the monoclonal nature and low efficiency of HTLV-1 transformation.

Indexed as

Human T-lymphotropic virus 1AnimalsApoptosisCells, CulturedCell Transformation, NeoplasticCisplatinDNA DamageDNA RepairDNA ReplicationDrug InteractionsFibroblastsFluorouracilGene Products, taxMutagensProliferating Cell Nuclear AntigenRatsCisplatinFluorouracilGene Products, taxMutagensProliferating Cell Nuclear Antigen

Identifiers

PMID10822374
OpenAlexW2058303120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.